PT3326619T - Composições farmacêuticas orais sólidas compreendendo tenofovir e emtricitabina - Google Patents

Composições farmacêuticas orais sólidas compreendendo tenofovir e emtricitabina

Info

Publication number
PT3326619T
PT3326619T PT172039729T PT17203972T PT3326619T PT 3326619 T PT3326619 T PT 3326619T PT 172039729 T PT172039729 T PT 172039729T PT 17203972 T PT17203972 T PT 17203972T PT 3326619 T PT3326619 T PT 3326619T
Authority
PT
Portugal
Prior art keywords
emtricitabine
tenofovir
pharmaceutical compositions
solid oral
oral pharmaceutical
Prior art date
Application number
PT172039729T
Other languages
English (en)
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret As filed Critical Sanovel Ilac Sanayi Ve Ticaret As
Publication of PT3326619T publication Critical patent/PT3326619T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT172039729T 2016-11-29 2017-11-28 Composições farmacêuticas orais sólidas compreendendo tenofovir e emtricitabina PT3326619T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2016/17448A TR201617448A2 (tr) 2016-11-29 2016-11-29 Tenofovi̇r ve emtri̇si̇tabi̇n i̇çeren kati oral farmasöti̇k bi̇leşi̇mler

Publications (1)

Publication Number Publication Date
PT3326619T true PT3326619T (pt) 2022-03-25

Family

ID=60569617

Family Applications (1)

Application Number Title Priority Date Filing Date
PT172039729T PT3326619T (pt) 2016-11-29 2017-11-28 Composições farmacêuticas orais sólidas compreendendo tenofovir e emtricitabina

Country Status (7)

Country Link
EP (1) EP3326619B1 (pt)
EA (1) EA201991286A1 (pt)
ES (1) ES2910924T3 (pt)
PL (1) PL3326619T3 (pt)
PT (1) PT3326619T (pt)
TR (1) TR201617448A2 (pt)
WO (1) WO2018099895A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021091498A1 (en) * 2019-11-06 2021-05-14 Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A.Ş. Pharmaceutical compositions comprising tenofovir and emtricitabine
CN112274488B (zh) * 2020-10-22 2022-08-26 安徽贝克生物制药有限公司 一种恩曲他滨、替诺福韦复方片及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040224917A1 (en) * 2003-01-14 2004-11-11 Gilead Sciences, Inc. Compositions and methods for combination antiviral therapy
AU2006325404B2 (en) 2005-12-14 2012-03-01 Cipla Limited Pharmaceutical combination comprising nucleotide and nucleoside reverse transcriptase inhibitors (such as tenofovir and lamivudine) in different parts of the dosage unit
WO2008096369A2 (en) * 2007-02-05 2008-08-14 Matrix Laboratories Limited Pharmaceutical formulation for use in hiv therapy
CA2744211A1 (en) * 2008-11-21 2010-05-27 Ultimorphix Technologies B.V. Wet granulation of tenofovir, emtricitabine and efavirenz
KR101923103B1 (ko) * 2010-11-19 2018-11-28 길리애드 사이언시즈, 인코포레이티드 릴피비린 hcl 및 테노포비어 디소프록실 푸마레이트를 포함하는 치료 조성물
DK2950786T3 (da) * 2013-01-31 2020-02-17 Gilead Pharmasset Llc Kombinationsformulering af to antivirale forbindelser
US20160199396A1 (en) * 2013-08-29 2016-07-14 Teva Pharmaceutical Industries Ltd. Unit dosage form comprising emtricitabine, tenofovir, darunavir and ritonavir and a monolithic tablet comprising darunavir and ritonavir
IN2013CH05288A (pt) * 2013-11-18 2015-09-11 Aurobindo Pharma Ltd
CZ2013985A3 (cs) 2013-12-09 2015-06-17 Zentiva, K.S. Stabilní farmaceutická kompozice obsahující tenofovir disoproxil fumarát

Also Published As

Publication number Publication date
TR201617448A2 (tr) 2018-06-21
ES2910924T3 (es) 2022-05-17
WO2018099895A1 (en) 2018-06-07
EP3326619A1 (en) 2018-05-30
PL3326619T3 (pl) 2022-06-06
EP3326619B1 (en) 2022-01-05
EA201991286A1 (ru) 2019-10-31

Similar Documents

Publication Publication Date Title
HK1248547A1 (zh) 包含替諾福韋和恩曲他濱的藥物製劑
IL262495B (en) History of isoquinolin-3-yl carboxamide and pharmaceutical preparations containing them
GB201620066D0 (en) Solid Pharmaceutical dosage formulations and processes
ZA201903101B (en) Pharmaceutical formulations
ZA201900275B (en) Oral gastroretentive formulations and uses thereof
HK1248544A1 (zh) 穩定的口服給藥用藥物組合物
EP3145508C0 (en) CLEVIDIPINE NANOPARTICLES AND PHARMACEUTICAL COMPOSITIONS THEREOF
HK1245113A1 (zh) 藥物組合物及其用途
HK1245646A1 (zh) 口服給藥用醫藥組合物
IL279877A (en) Ibusidanib forms and pharmaceutical preparations
EP3497080A4 (en) PHARMACEUTICAL FORMULATIONS AND THEIR USE
PT3326619T (pt) Composições farmacêuticas orais sólidas compreendendo tenofovir e emtricitabina
IL254711B (en) History of diazepine-indole and medicinal preparations containing them
IL271908A (en) Over-compressed pharmaceutical preparations
ZA201903341B (en) Pharmaceutical compositions and uses thereof
GB2569616B (en) Sustained release oral pharmaceutical compositions of dicycloverine
EP3560492C0 (en) COMPOSITION OF LIPID PARTICLES AND PHARMACEUTICAL COMPOSITION
GB201812022D0 (en) Pharmaceutical methods and compositions
GB201713920D0 (en) Pharmaceutical compositions and uses thereof
GB201604810D0 (en) Pharmaceutical compositions and uses
GB201610440D0 (en) Pharmaceutical formulations
AU2015901459A0 (en) Pharmaceutical powder composition and use